Related Experiment Video
Updated: Feb 8, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Long Non-Coding RNA in Glioma: Target miRNA and Signaling Pathways
Background:
Glioma is one of the most common and aggressive malignant tumors of the central nervous system.
Methods:
Here, we review and explore the use of long noncoding RNA (lncRNA) as a therapeutic strategy for the targeting of gliomas.
Results:
LncRNA is a functional RNA molecule with no protein coding function and is involved in the occurrence and progression of glioma. It is reported that the activation of several signaling pathways, including the MAPK, p53, Wnt/β-catenin, PI3K/AKT/mTOR, and epithelial mesenchymal transformation (EMT) pathways, are involved in the regulation of gliomas. In addition, microRNAs in glioma may also interact with lncRNAs and affect tumor growth and progression.
Conclusions:
Therefore, the exploration of lncRNA participation in signaling pathway regulatory mechanisms and the determination of the interaction between lncRNA and miRNA may help to develop new effective therapies for the treatment of glioma.
Insights
Long noncoding RNAs (lncRNAs) are key players in glioma development and progression. Targeting lncRNAs offers a promising therapeutic strategy for treating this aggressive central nervous system cancer.
Area of Science:
- Neuro-oncology
- Molecular Biology
- RNA Therapeutics
Background:
- Glioma represents a significant challenge as a common and aggressive central nervous system malignancy.
- Understanding the molecular underpinnings of glioma is crucial for developing effective treatments.
Purpose of the Study:
- To review and explore the potential of long noncoding RNAs (lncRNAs) as a therapeutic strategy for glioma.
- To investigate the role of lncRNAs in glioma pathogenesis and progression.
Main Methods:
- Literature review and analysis of existing research on lncRNAs in glioma.
- Exploration of lncRNA involvement in key signaling pathways implicated in glioma.
Main Results:
- lncRNAs are non-protein-coding functional RNA molecules implicated in glioma occurrence and progression.
- lncRNAs regulate critical signaling pathways such as MAPK, p53, Wnt/β-catenin, PI3K/AKT/mTOR, and EMT in gliomas.
- Interactions between lncRNAs and microRNAs (miRNAs) influence glioma growth and progression.
Conclusions:
- lncRNA participation in signaling pathway regulation is vital for glioma development.
- Determining lncRNA-miRNA interactions can pave the way for novel and effective glioma therapies.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
lncRNA - Long Non-coding RNAs
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway

